Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
cancer immunotherapy
clinical trials
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
bristol-myers squibb
deals
eli lilly
fda
investing
johnson & johnson
alzheimer's disease
What
drug
4
×
roundup
bio
annual
attention
biotech
companies
nash
news
ahead
alzheimer’s
ambien
american
approval
approved
asco
assessed
attendees
biogen’s
biopharmaceutical
camp’s
cancer
cash
chicago
city
clinical
combinations
communities
community’s
conference
convo
days
digital
disease
earlier
epidemic
esmo
europe
expanding
failures
Language
Current search:
cancer
×
startups
×
drug
×
" clinical trials "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More